MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Repligen Corporation Cash and Cash Equivalents 2011-2026 | RGEN
Annual Cash and Cash Equivalents Repligen Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 751 M | 523 M | 604 M | 717 M | 528 M | 194 M | 174 M | 122 M | 54.1 M | 35.4 M | 39.8 M | 29.2 M | 11.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 751 M | 11.2 M | 291 M |
Quarterly Cash and Cash Equivalents Repligen Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 749 M | 709 M | 697 M | 757 M | 784 M | 809 M | 781 M | 751 M | 631 M | 604 M | 517 M | 523 M | 573 M | 597 M | 585 M | 604 M | 621 M | 734 M | 711 M | 717 M | 717 M | 717 M | 717 M | 528 M | 528 M | 528 M | 528 M | 194 M | 194 M | 194 M | 194 M | 174 M | 174 M | 174 M | 174 M | 122 M | 122 M | 122 M | 122 M | 54.1 M | 54.1 M | 54.1 M | 54.1 M | 35.4 M | 35.4 M | 35.4 M | 35.4 M | 39.8 M | 39.8 M | 39.8 M | 39.8 M | 29.2 M | 29.2 M | 29.2 M | 29.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 809 M | 11.2 M | 345 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
1.76 B | $ 20.07 | 1.7 % | $ 10.2 B | USA |
 |
ICU Medical
ICUI
|
309 M | $ 150.64 | 0.41 % | $ 3.67 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
6.49 M | $ 8.5 | 1.31 % | $ 171 M | USA |
 |
Alcon
ALC
|
1.68 B | $ 81.15 | 0.02 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
11.5 M | $ 5.47 | 0.37 % | $ 249 M | USA |
 |
AtriCure
ATRC
|
123 M | $ 37.09 | 0.38 % | $ 1.74 B | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 66.22 | 0.38 % | $ 3.33 B | USA |
 |
electroCore
ECOR
|
10.3 M | $ 6.56 | -7.53 % | $ 36.2 K | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.46 | 4.83 % | $ 427 M | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 8.27 | 2.86 % | $ 171 M | USA |
 |
The Cooper Companies
COO
|
111 M | $ 81.14 | 0.96 % | $ 16.2 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 136.3 | 0.04 % | $ 7.26 B | USA |
 |
Harvard Bioscience
HBIO
|
4.28 M | $ 0.51 | -4.57 % | $ 21.6 M | USA |
 |
OraSure Technologies
OSUR
|
268 M | $ 2.75 | -1.27 % | $ 205 M | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 119.79 | 0.7 % | $ 5.8 B | USA |
 |
Merit Medical Systems
MMSI
|
377 M | $ 81.94 | 2.12 % | $ 4.77 B | USA |
 |
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
420 M | $ 154.04 | 3.39 % | $ 4.81 B | USA |
 |
LeMaitre Vascular
LMAT
|
25.6 M | $ 84.67 | 0.97 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
2.03 B | $ 504.38 | -0.62 % | $ 179 B | USA |
 |
STERIS plc
STE
|
172 M | $ 261.58 | -0.1 % | $ 25.8 B | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
2.47 M | $ 1.82 | -2.15 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
4.31 M | $ 4.35 | -0.91 % | $ 45.2 M | USA |
 |
Utah Medical Products
UTMD
|
92.9 M | $ 61.22 | -0.71 % | $ 222 M | USA |
 |
Milestone Scientific
MLSS
|
3.26 M | $ 0.3 | 0.29 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.07 B | $ 23.26 | -0.47 % | $ 4.01 B | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 38.97 | -1.1 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
735 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 13.8 | 1.32 % | $ 663 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 203.51 | 1.21 % | $ 58.5 B | USA |
 |
ResMed
RMD
|
274 M | $ 254.15 | -1.35 % | $ 37.1 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 21.9 | -3.01 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
19.8 M | $ 2.24 | -4.28 % | $ 181 M | USA |
 |
Retractable Technologies
RVP
|
4.24 M | $ 0.71 | -0.13 % | $ 21.3 M | USA |
 |
STAAR Surgical Company
STAA
|
144 M | $ 18.96 | 0.11 % | $ 931 M | USA |
 |
Teleflex Incorporated
TFX
|
290 M | $ 104.64 | -0.77 % | $ 4.9 B | USA |
 |
West Pharmaceutical Services
WST
|
485 M | $ 229.14 | -1.44 % | $ 16.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
272 M | $ 12.51 | 1.92 % | $ 2.54 B | USA |